Arcutis Biotherapeutics, Inc.
US ˙ NasdaqGS ˙ US03969K1088

SecurityARQT / Arcutis Biotherapeutics, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership48,337 shares
Latest Disclosed Value $ 1,138,819
Citigroup Inc reports 12.35% decrease in ownership of ARQT / Arcutis Biotherapeutics, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 48,337 shares of Arcutis Biotherapeutics, Inc. (US:ARQT) valued at $1,138,820 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 55,146 shares of Arcutis Biotherapeutics, Inc.. This represents a change in shares of -12.35% during the quarter. The current value of the position is $1,026,195 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 48,337 -6,809 -12.35 1,139 -28.92 0.0002
2026-02-13 2025-12-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 55,146 9,235 20.12 1,601 85.09 0.0007
2025-11-10 2025-09-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 45,911 -313,511 -87.23 865 -82.83 0.0004
2025-08-11 2025-06-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 359,422 57,870 19.19 5,039 6.85 0.0025
2025-05-12 2025-03-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 301,552 -25,713 -7.86 4,716 3.47 0.0024
2025-02-12 2024-12-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 327,265 237,643 265.16 4,559 447.18 0.0027
2024-11-12 2024-09-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 89,622 35,023 64.15 833 64.30 0.0005
2024-08-12 2024-06-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 54,599 -661,841 -92.38 508 -92.86 0.0003
2024-05-10 2024-03-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 716,440 703,727 5,535.49 7,100 17,214.63 0.0047
2024-02-09 2023-12-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 12,713 -164,109 -92.81 41 -95.63 0.0000
2023-12-06 2023-09-30 13F/A-1 ARCUTIS BIOTHERAPEUTICS COM 03969K108 176,822 23,234 15.13 939 -35.89 0.0007
2023-11-09 2023-09-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 176,822 23,234 939 0.0003
2023-08-10 2023-06-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 153,588 -90,411 -37.05 1,464 -45.47 0.0010
2023-05-11 2023-03-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 243,999 110,771 83.14 2,684 36.12 0.0019
2023-02-09 2022-12-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 133,228 -27,273 -16.99 1,972 -35.74 0.0016
2022-11-10 2022-09-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 160,501 114,683 250.30 3,067 214.24 0.0022
2022-08-10 2022-06-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 45,818 34,215 294.88 976 337.67 0.0007
2022-05-12 2022-03-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 11,603 -108,637 -90.35 223 -91.06 0.0001
2022-02-10 2021-12-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 120,240 95,304 382.19 2,494 318.46 0.0013
2021-11-10 2021-09-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 24,936 -36,483 -59.40 596 -64.44 0.0004
2021-08-10 2021-06-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 61,419 8,087 15.16 1,676 8.62 0.0010
2021-05-13 2021-03-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 53,332 47,904 882.54 1,543 908.50 0.0010
2021-02-11 2020-12-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 5,428 -4,456 -45.08 153 -47.24 0.0001
2020-11-12 2020-09-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 9,884 6,873 228.26 290 218.68 0.0002
2020-08-12 2020-06-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 3,011 -3 -0.10 91 1.11 0.0001
2020-05-12 2020-03-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 3,014 3,014 90 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.